Dementia and Geriatric Cognitive Disorders
Original Research Article
Vascular Cognitive Impairment: Prodromal Stages of Ischemic Vascular DementiaRamos-Estébanez C.a · Moral-Arce I.b · Muñoz-Arrondo R.c · González-Mandly A.d · Matorras-Galán P.e, f · González-Macias J.e, f · Hernández-Hernández J.L.e, faAlbert Einstein College of Medicine, Internal Medicine Department, Center for Non-Invasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School, Bronx, N.Y., USA; bSpanish National Institute of Statistics, Madrid; cDepartment of Neurology, Stroke Unit, Navarra Hospital, University of Navarra, Pamplona, dDepartment of Radiology, Division of Neuroradiology, Marques de Valdecilla University Hospital, eDepartment of Internal Medicine, Marques de Valdecilla University Hospital, University of Cantabaria, and fDepartment of Medicine and Psychiatry, University of Cantabaria, Santander, Spain
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: December 13, 2006
Accepted: August 30, 2007
Published online: April 10, 2008
Issue release date: April 2008
Number of Print Pages: 10
Number of Figures: 2
Number of Tables: 5
ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)
For additional information: https://www.karger.com/DEM
Abstract
Background/Aims: To describe the natural history of the prodromal stages of ischemic vascular dementia (pVaD). Methods: A sample of 314 inpatients with pVaD or a clini- cal diagnosis of vascular dementia (VaD; lacunar state, Binswanger’s disease, pure cortical VaD, corticosubcortical and strategic infarctions) admitted to a teaching tertiary center during a 13-year period was assessed (retrospectively n = 88, prospectively n = 226). Prospective neuropsychological assessment consisted of Mini Mental State Examination, Revised Wechsler Adult Intelligence Scale, Exit-25, Trail Making tests, Blessed Dementia Scale and Camdex H, Global Depression Scale and Hamilton Depression Rating Scale tests. Univariate analysis and logistic regressions are displayed. Results: An unrecognized pVaD was related with a clinical onset with cognitive impairment no dementia (CIND) versus symptomatic cerebrovascular events (p < 0.0001), and with being under therapy with anticoagulant or antiplatelet agents (p < 0.01). Age <85 years at diagnosis of VaD (p < 0.01) correlated with a delayed pVaD diagnosis. CIND onset was associated with a longer prodromal stage (p < 0.01), no clinical strokes during pVaD (p < 0.001), silent ischemia (p < 0.01) and Binswanger’s disease (p < 0.01). Conclusions: Vascular cognitive impairment remains an underdiagnosed, yet treatable entity. A brief neuropsychological examination and informant interviews should become standard practice in elderly populations with vascular risk factors. Small-vessel disease is a prevalent condition with a distinct natural history.
© 2008 S. Karger AG, Basel
Related Articles:
References
- Chui EC, Mack W, Jackson JE, et al: Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and inter-rater reliability. Arch Neurol 2000;57:191–196.
- Pohjasvaara T, Mäntyla R, Aronen HJ, et al: Clinical and radiological determinants of prestroke decline in a stroke cohort. J Neurol Neurosurg Psychiatry 1999;67:742–748.
- Henon H, Pasquir F, Durieu I: Preexisting dementia in stroke patients: baseline frequency, associated factors, and outcome. Stroke 1997;28:2429–2436.
- Henon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D: Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001;57:1216–1222.
- Tatemichi TK, Desmond DW, Stern Y: Cognitive impairment after stroke: frequency, patterns, and relationships to functional abilities. J Neurol Neurosurg Psychiatry 1994;57:202–204.
- Rockwood K, Wentzel C, Hachinski V, Hogan DB, McKnight C, McDowell I: Prevalence and outcomes of vascular cognitive impairment. Neurology 2000;54:447–451.
- Wentzel C, Rockwood K, McKnight C, et al: Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001;57:714–716.
- Engels JL, Wentzel C, Fisk JD, Rockwood K: Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke 2002;33:1999–2002.
- Unverzagt FW, Gao S, Baiyewu O, et al: Prevalence of cognitive impairment: data from the Indianapolis Study for Health and Aging. Neurology 2001;57:1655–1662.
- Wetterling T, Kanitz RD, Borgis KJ: Comparison of different criteria for vascular dementia. Stroke 1996;27:30–36.
- Pohkasvaara T, Mantila R, Ylikloski R, Kaste M, Erkinjuntti T: Comparison of clinical different criteria for the comparison of vascular dementia. Stroke 2000;31:2952–2957.
- Mok V, Wong A, Tang WK, et al: Determinants of prestroke cognitive impairment in stroke associated with small vessel disease. Dementia Geriatr Cogn Disord 2005;20:225–230.
- Folstein MF, Folstein SE, MacHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–191.
-
Fan E, Royall DR, Chiodo LK, et al: Insight into financial capacity in non-institutionalized retirees (abstract). J Am Geriatr Soc 2003;50:S80.
- Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975;32:632–637.
-
Wechsler D: Wechsler Adult Intelligence Scale, Revised. New York, Psychological Corporation, 1981.
- Satz P, Mogel S: An abbreviation of the WAIS for clinical use. J Clin Psychol 1962;18:77–79.
- Royall DR, Mahurin RK, Gray KF: Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc 1992;40:1221–1226.
-
Reitan R: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Motor Skills 1958;8:271–276.
External Resources
- Yesavage JA, Brink TL, Rose TL, et al: Development and validation of a geriatric depression scale: a preliminary report. J Psychiatr Res 1982;17:37–49.
- Hamilton MA: A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;23:56–62.
- Blessed G, Tomlinson BE, Roth M: The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797–811.
- Roth M, Tym E, Mountjoy CQ, et al: CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to early detection of dementia. Br J Psychiatry 1986;149:698–709.
- Serrano S, Domingo J, Rodriguez-Garcia E, Castro MD, Del Ser T: Frequency of cognitive impairment without dementia in patients with stroke: a two-year follow-up study. Stroke 2007;38:105–110.
-
Lezak: Neuropsychological Assessment, ed 3. New York, Oxford University Press, 1995.
- Albert MS, Moss MB, Tanzi R, Jones K: Preclinical prediction of DAT using neuropsychological tests. J Int Neuropsychiatr Soc 2001;7:631–639.
- Chen P, et al: Patterns of cognitive decline in presymptomatic DAT: a prospective community study. Arch Gen Psychiatry 2001;58:853–858.
- Jones S, Laukka EJ, Small BJ, Fratiglioni L, Backman L: A preclinical phase in VaD: cognitive impairment three years before diagnosis. Dementia Geriatr Cogn Disord 2004;18:233–239.
- Tombaugh TN: Trail making test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 2004;19:203–214.
- Bogousslavsky J: The plurality of subcortical infarction. Stroke 1992;23:629–631.
- Caplan LR: Binswanger’s disease – revisited. Neurology 1995;45:626–633.
- Bennett DA, Wilson RS, Gilley DW, Fox JH: Clinical diagnosis of Binswanger’s disease. J Neurol Neurosurg Psychiatry 1990;53:961–965.
- Chui HC, Victoroff JI, Margolin D, et al: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 1992;42:473–480.
- Mahler ME, Cummings JL: Behavioral neurology of multiinfarct dementia. Alzheimer Dis Assoc Disord 1991;5:122–130.
- Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: diagnostic criteria for research criteria for research studies (report of the NINCDS-AIREN International Work Group). Neurology 1993;43:250–260.
- Konno S, Meyer JS, Terayama Y, Margishvili GM, Mortel KF: Classification, diagnosis and treatment of vascular dementia. Drugs Aging 1997;11:361–373.
- Joint National Committee: Sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413.
- Expert Committee on the diagnosis and classification of diabetes mellitus: Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183.
-
Efron B, Gong G: A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat 1983;37:36–48.
External Resources
- Kase CS: Epìdemiology of multiinfarct dementia. Alzheimer Dis Assoc Disord 1991;5:71–76.
- Levy R: Aging associated cognitive decline. Int Psychogeriatr 1994;6:63–68.
- Petersen RC, Doody R, Kurz A, et al: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992.
- Sacuiu S, Sjogrën M, Johansonn B, Gustafson D, Skoog I: Prodromal cognitive signs of dementia in 85-year-olds using four sources of information. Neurology 2005;65:1894–1900.
- Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB: Progression to dementia in patients with isolated memory loss. Lancet 1997;349:763–765.
- Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL: Mild cognitive impairments predict dementia in non-demented elderly patients with memory loss. Arch Neurol 2001;58:411–416.
- Royall DR: Executive cognitive impairment: a novel perspective on dementia. Neuroepidemiology 2000;19:293–299.
- Vermeer, SE, Prins MD, Heijer T, et al: Silent brain infarcts and the risk of dementia and cognitive decline. NEJM 2003;348:1215–1222.
- Liebetrau M, Steen B, Hamann G, Skoog I: Silent and symptomatic infarcts in CAT scan in relation to dementia and mortality. Stroke 2004;35:1816–1820.
- Laupacis A, Wells G, Richardson W, Tugwell P, for the Evidence Based Medicine Working Group: User’s guide to the medical literature. V. How to use an article about prognosis. JAMA 1994;272:234–237.
Article / Publication Details
Received: December 13, 2006
Accepted: August 30, 2007
Published online: April 10, 2008
Issue release date: April 2008
Number of Print Pages: 10
Number of Figures: 2
Number of Tables: 5
ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)
For additional information: https://www.karger.com/DEM
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission